Lupin s U.S. Commercial Women s Health Specialty Business - Ownership and Business Overview

Life ScienceCompany

Lupin s U.S. Commercial Women s Health Specialty Business Ownership

Who owns Lupin s U.S. Commercial Women s Health Specialty Business?

Lupin s U.S. Commercial Women s Health Specialty Business is owned by Lupin. It was acquired on July 15, 2024.

Lupin s U.S. Commercial Women s Health Specialty Business Business Overview

Where is Lupin s U.S. Commercial Women s Health Specialty Business headquartered?

Lupin s U.S. Commercial Women s Health Specialty Business is headquartered in Baltimore, Maryland.

What sector is Lupin s U.S. Commercial Women s Health Specialty Business in?

Lupin s U.S. Commercial Women s Health Specialty Business is a life science company.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 201 acquisitions of life science companies in 2024, including 20 acquisitions by private equity firms, and 181 by strategics.

Lupin's U.S. Commercial Women's Health Specialty Business

Lupin Ltd. - U.S. Commercial Women's Health Specialty Business

Baltimore, Maryland
United States,

Lupin's U.S. Commercial Women's Health Specialty Business is focused on commercializing SOLOSEC (secnidazole) 2g oral granules. It is an FDA-approved single-dose antimicrobial agent that provides a complete course of therapy for the treatment of bacterial vaginosis (BV) and trichomoniasis, two common sexual health infections.


 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.